TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  14nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells com...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  197nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  29nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  52nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  15nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  176nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  145nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  89nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  117nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells com...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  13nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells com...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  327nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  1.30nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells com...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50: >1.00E+4nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells com...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  139nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells com...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  542nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells com...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50: >1.00E+3nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells com...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataKd:  250nMAssay Description:Binding affinity to HIV1 gp41 (46 residues) by surface plasmon resonance methodMore data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataKd:  182nMAssay Description:Binding affinity to HIV1 gp41 (46 residues) by surface plasmon resonance methodMore data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataKd:  452nMAssay Description:Binding affinity to HIV1 gp41 (46 residues) by surface plasmon resonance methodMore data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  20nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  10nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  2.18E+3nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  3.58E+3nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  3.24E+3nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50: >1.00E+5nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50: >1.00E+5nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50: >1.00E+5nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  3.30nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  3.40nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  7.90nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  3.90nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataEC50:  44nMAssay Description:Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells aft...More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataIC50: 610nMAssay Description:Inhibition of HIV-1 isolate YTA48P HIV-1 gp120More data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataIC50: 2.84E+3nMAssay Description:Inhibition of HIV1 gp41 NHR assessed as inhibition of 6HB formation by FRET assayMore data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataIC50: 8.31E+3nMAssay Description:Inhibition of HIV1 gp41 NHR assessed as inhibition of 6HB formation by FRET assayMore data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataIC50: 8.31E+3nMAssay Description:Inhibition of HIV1 gp41 NHR assessed as inhibition of 6HB formation by FRET assayMore data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataIC50: 8.31E+3nMAssay Description:Inhibition of HIV1 gp41 NHR assessed as inhibition of 6HB formation by FRET assayMore data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataIC50: 8.31E+3nMAssay Description:Inhibition of HIV1 gp41 NHR assessed as inhibition of 6HB formation by FRET assayMore data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataIC50: 8.31E+3nMAssay Description:Inhibition of HIV1 gp41 NHR assessed as inhibition of 6HB formation by FRET assayMore data for this Ligand-Target Pair
TargetEnv polyprotein(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology & Toxicology
Curated by ChEMBL
Affinity DataIC50: 8.31E+3nMAssay Description:Inhibition of HIV1 gp41 NHR assessed as inhibition of 6HB formation by FRET assayMore data for this Ligand-Target Pair
 
 	























